Benjamin Franklin Cravatt is a professor in and chair of the Department of Chemical Physiology at The Scripps Research Institute in La Jolla, California. Considered the co-inventor of activity based proteomics with Matthew Bogyo, he is a prominent figure in the nascent field of chemical biology.
| Property | Value |
| dbpedia-owl:Person/knownFor
| |
| dbpedia-owl:knownFor
| |
| dbpedia-owl:thumbnail
| |
| dbpprop:abstract
|
- Benjamin Franklin Cravatt is a professor in and chair of the Department of Chemical Physiology at The Scripps Research Institute in La Jolla, California. Considered the co-inventor of activity based proteomics with Matthew Bogyo, he is a prominent figure in the nascent field of chemical biology. His early contributions to the cannabinoid field include identification and characterization of the endocannabinoid-terminating enzyme fatty acid amide hydrolase, FAAH, as well as the isolation of the novel soporific compound oleamide from cerebrospinal fluid . Since these contributions, his research program has expanded to include proteomics, metabolomics, and chemical methods for functionally annotating the roles of serine hydrolase enzymes in cancer and endocannabinoid signaling. Cravatt is a Cope and Searle Scholar, and the co-founder of ActivX Biosciences.
|
| dbpprop:field
| |
| dbpprop:hasPhotoCollection
| |
| dbpprop:imageWidth
| |
| dbpprop:knownFor
| |
| dbpprop:name
| |
| dbpprop:reference
| |
| dbpprop:wikiPageUsesTemplate
| |
| dbpprop:wordnet_type
| |
| dbpprop:workInstitution
| |
| rdf:type
| |
| rdfs:comment
|
- Benjamin Franklin Cravatt is a professor in and chair of the Department of Chemical Physiology at The Scripps Research Institute in La Jolla, California. Considered the co-inventor of activity based proteomics with Matthew Bogyo, he is a prominent figure in the nascent field of chemical biology.
|
| rdfs:label
| |
| owl:sameAs
| |
| skos:subject
| |
| foaf:depiction
| |
| foaf:name
| |
| foaf:page
| |
| is dbpprop:redirect
of | |
| is owl:sameAs
of | |